These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
214 related items for PubMed ID: 18656539
1. In vitro cytotoxicity, in vivo biodistribution and antitumor activity of HPMA copolymer-5-fluorouracil conjugates. Yuan F, Qin X, Zhou D, Xiang QY, Wang MT, Zhang ZR, Huang Y. Eur J Pharm Biopharm; 2008 Nov; 70(3):770-6. PubMed ID: 18656539 [Abstract] [Full Text] [Related]
2. [In vitro release study, in vivo evaluation of biodistribution and antitumor activity of HPMA copolymer-5-fluorouracil conjugates]. Yuan F, Zhang ZR, Yang YX, Huang Y. Yao Xue Xue Bao; 2008 Nov; 43(11):1152-6. PubMed ID: 19239037 [Abstract] [Full Text] [Related]
3. Synthesis and in vitro anti-tumor activity of novel HPMA copolymer-drug conjugates with potential cell surface targeting property for carcinoma cells. Xiang Q, Yang Y, Zhou Z, Zhou D, Jin Y, Zhang Z, Huang Y. Eur J Pharm Biopharm; 2012 Feb; 80(2):379-86. PubMed ID: 22101181 [Abstract] [Full Text] [Related]
4. Treatment of prostate carcinoma with (galectin-3)-targeted HPMA copolymer-(G3-C12)-5-Fluorouracil conjugates. Yang Y, Zhou Z, He S, Fan T, Jin Y, Zhu X, Chen C, Zhang ZR, Huang Y. Biomaterials; 2012 Mar; 33(7):2260-71. PubMed ID: 22189143 [Abstract] [Full Text] [Related]
5. Development of novel 5-fluorouracil carrier erythrocyte with pharmacokinetics and potent antitumor activity in mice bearing malignant ascites. Wang GP, Guan YS, Jin XR, Jiang SS, Lu ZJ, Wu Y, Li Y, Li M, Luo F. J Gastroenterol Hepatol; 2010 May; 25(5):985-90. PubMed ID: 20546454 [Abstract] [Full Text] [Related]
8. The effect of calmodulin antagonist berbaminederivative-EBB on hepatoma in vitro and in vivo. Liu J, Qi S, Zhu H, Zhang J, Li Z, Wang T. Chin Med J (Engl); 2002 May; 115(5):759-62. PubMed ID: 12133551 [Abstract] [Full Text] [Related]
9. Pharmacokinetic properties and antitumor efficacy of the 5-fluorouracil loaded PEG-hydrogel. Yi H, Cho HJ, Cho SM, Lee DG, Abd El-Aty AM, Yoon SJ, Bae GW, Nho K, Kim B, Lee CH, Kim JS, Bartlett MG, Shin HC. BMC Cancer; 2010 May 18; 10():211. PubMed ID: 20482808 [Abstract] [Full Text] [Related]
14. Cytotoxicity and antitumour activity of 5-fluorouracil-loaded polyhydroxybutyrate and cellulose acetate phthalate blend microspheres. Chaturvedi K, Tripathi SK, Kulkarni AR, Aminabhavi TM. J Microencapsul; 2013 May 18; 30(4):356-68. PubMed ID: 23078151 [Abstract] [Full Text] [Related]
15. In vivo tumor targeting and anti-tumor effects of 5-fluororacil loaded, folic acid targeted quantum dot system. Bwatanglang IB, Mohammad F, Yusof NA, Abdullah J, Alitheen NB, Hussein MZ, Abu N, Mohammed NE, Nordin N, Zamberi NR, Yeap SK. J Colloid Interface Sci; 2016 Oct 15; 480():146-158. PubMed ID: 27428851 [Abstract] [Full Text] [Related]
16. [Biodistribution of N-(2-hydroxypropyl) methacrylamide copolymer-bound mitoxantrone in mice bearing Ehrlich solid tumor]. Huang Y, Zhang Z, Liu W. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Dec 15; 21(6):930-4. PubMed ID: 15646335 [Abstract] [Full Text] [Related]
17. Synthesis of galactosylated chitosan/5-fluorouracil nanoparticles and its characteristics, in vitro and in vivo release studies. Cheng M, Han J, Li Q, He B, Zha B, Wu J, Zhou R, Ye T, Wang W, Xu H, Hou Y. J Biomed Mater Res B Appl Biomater; 2012 Nov 15; 100(8):2035-43. PubMed ID: 22865703 [Abstract] [Full Text] [Related]
18. Ethogel topical formulation for increasing the local bioavailability of 5-fluorouracil: a mechanistic study. Puri R, Jain S. Anticancer Drugs; 2012 Oct 15; 23(9):923-34. PubMed ID: 22926258 [Abstract] [Full Text] [Related]
19. Synthesis of Biotin-Modified Galactosylated Chitosan Nanoparticles and Their Characteristics in Vitro and in Vivo. Cheng M, Ma D, Zhi K, Liu B, Zhu W. Cell Physiol Biochem; 2018 Oct 15; 50(2):569-584. PubMed ID: 30308481 [Abstract] [Full Text] [Related]
20. Fluorouracil-Loaded Gold Nanoparticles for the Treatment of Skin Cancer: Development, in Vitro Characterization, and in Vivo Evaluation in a Mouse Skin Cancer Xenograft Model. Safwat MA, Soliman GM, Sayed D, Attia MA. Mol Pharm; 2018 Jun 04; 15(6):2194-2205. PubMed ID: 29701979 [Abstract] [Full Text] [Related] Page: [Next] [New Search]